Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect
Prognostic markers in renal cell carcinoma: A focus on the 'mammalian target of rapamycin' pathway - ScienceDirect
![Sensitivity and specificity of important tumor markers [76] | Download Table](https://www.researchgate.net/publication/236093730/figure/tbl2/AS:393333642940428@1470789456330/Sensitivity-and-specificity-of-important-tumor-markers-76.png "Sensitivity and specificity of important tumor markers [76] | Download Table")
Sensitivity and specificity of important tumor markers [76] | Download Table
Renal cell carcinoma - Knowledge @ AMBOSS
![Sensitivity and specificity of important tumor markers [76] | Download Table](https://www.researchgate.net/profile/Damodaran-Vasudevan/publication/236093730/figure/tbl2/AS:393333642940428@1470789456330/Sensitivity-and-specificity-of-important-tumor-markers-76_Q640.jpg "Sensitivity and specificity of important tumor markers [76] | Download Table")
Sensitivity and specificity of important tumor markers [76] | Download Table
Renal Tumors of Childhood: Radiologic-Pathologic Correlation Part 2. The 2nd Decade: From the Radiologic Pathology Archives | RadioGraphics
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity | Nature Communications
Existing noninvasive tumor markers that are in routine clinical use for... | Download Table
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice
Current Management of Small Renal Masses, Including Patient Selection, Renal Tumor Biopsy, Active Surveillance, and Thermal Ablation | Journal of Clinical Oncology
Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma Chauhan A, Bhattacharyya S, Ojha R, Mandal AK, Singh SK - J Can Res Ther
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
PDF) Chapter 4 CLINICAL USE OF TUMOR MARKERS
Renal-Cell Carcinoma | NEJM
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
Classification of renal cell tumors – current concepts and use of ancillary tests: recommendations of the Brazilian Society of Pathology | Surgical and Experimental Pathology | Full Text
Tumor Marker Tests Overused in Primary and Secondary Care - Pathology - Labmedica.com
Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors | Science
![PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7896471207c8fe77bab199b437597b9ca881227b/5-TableIII-1.png "PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar")
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
Renal-Cell Carcinoma | NEJM
Human Kidney Injury Molecule-1 Is a Tissue and Urinary Tumor Marker of Renal Cell Carcinoma | American Society of Nephrology
Kidney cancers
